The Anti-Cardiolipin Screen is a semi-quantitative immunoassay for the determination of IgG, IgM and IgA antibodies against nuclear and cytoplasmic antigens in human serum. The Anti-Cardiolipin Screen is intended as an aid in the diagnosis of anti-phospholipid antibody syndrome (APAS) in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4014 – Anti-Cardiolipin Screen
Autoimmunity, Diagnostics, ELISA
4014 – Anti-Cardiolipin Screen
Enzyme immunoassay for the semi-quantitative determination of IgG, IgM and IgA antibodies against Cardiolipin in human serum
Available Downloads:
| Indication | Anti-phospholipid syndrome (APAS) |
|---|---|
| Format | Microtiter plate coated with cardiolipin complex |
| Total incubation time | 105 min. |
| No. of determinations | 96 (93 x 1) + 1 x Calibrator + 2 x Controls |
Related products
-
3507 – Medizym® anti-GAD M
Enzyme immunoassay for the quantitative determination of antibodies against Glutamic Acid Decarboxylase (GAD65) in human serum
-
3750 – Anti-GP2 IgA
Enzyme immunoassay for the quantitative determination of IgA antibodies against glycoprotein 2 (GP2) in human serum
-
3806 – Medizym® IAA
Enzyme immunoassay for the quantitative determination of IgG antibodies against insulin in human serum